Exomega Control Emollient Cream
Daily Atopic Companion
Pros & cons.
- +Same evidence-backed active set as the Exomega Control balm
- +Lighter cream texture suited to year-round daily use
- +Absorbs in about a minute into a non-greasy finish
- +Safe for atopic-prone children and adults across ages
- +AFPADA atopic skin recommendation
- +Pairs well with prescription eczema treatments
- +Better suited to warmer climates than the balm variant
- −Insufficient for severely dry atopic-prone skin in deep winter
- −Less occlusive than the balm for nighttime sealing
- −Price is higher than drugstore equivalents
- −Does not replace prescription treatment during active flares
- −Limited US retail distribution compared to European markets
The full review.
When a dermatologist says atopic-prone skin needs moisturizer twice a day, every day, head to toe, the real question isn’t about fancy ingredients. It is about which product you will actually use for twelve months. Adherence determines outcomes in atopic skin management. A balm that is too heavy for your climate gets skipped in summer. A cream that is too light for winter skin gets replaced by something heavier, and then you forget to restock and return to zero. A-Derma developed the Exomega Control Cream because pediatric dermatology partners requested a lighter version of the Exomega balm that passes the ‘daily use for a year’ test across more users and seasons.
This formula is the cream-textured version of the Exomega Control Emollient Balm reviewed elsewhere in this database. It uses the same core active ingredients: Rhealba oat extract for anti-inflammatory support, sunflower oil unsaponifiables for essential-fatty-acid replenishment, niacinamide to drive endogenous ceramide-synthesis, and shea butter as the emollient backbone. The water-to-lipid ratio and emollient esters differ. This version uses caprylic/capric triglyceride instead of mineral oil for the core emollient, which provides lighter slip and faster absorption without changing the core repair mechanism. The Exomega Control Cream feels lighter on the skin than the balm and absorbs in about a minute, but still delivers the key Exomega actives to atopic-prone skin at meaningful concentrations.
The cream feels soft and cushiony, not occlusive. It spreads easily, sinks in, and leaves skin feeling comforted rather than coated. This helps atopic-prone users who find the balm too rich for summer or too heavy for daily body application. For adults with mild to moderate atopic-prone skin on arms, legs, and torso, the cream is often the more realistic daily choice. For kids who kick off sheets and cannot tolerate heavy products on bare skin, the cream is easier to use. In temperate climates, it fits a year-round routine. The balm has a narrower use case: severe winter dryness, severely dry atopic-prone patches, and cold-climate daily use.
Consistent use shows that the cream and the balm converge. Applied twice a day to eczema-prone skin, both versions reduce flare frequency and severity within a few weeks. The cream may take longer to smooth extremely dry patches—the balm remains better for the worst skin—but for most atopic-prone users, the cream is functionally equivalent and practically superior. The niacinamide driving endogenous ceramide synthesis works regardless of texture, the sunflower oil unsaponifiables provide the same essential fatty acids, and the Rhealba oat is anti-inflammatory at the concentrations used in both products.
Limitations are minor. For severely dry atopic-prone skin in deep winter, this cream is not enough alone; layer a heavier balm on the worst patches at night, or use the balm in cold months and the cream in warmer weather. The 200ml airless pump is standard, but a 400ml size is available in some markets and offers better value for heavy users. Like the balm, this cream is a supportive product, not a treatment; it reduces flare frequency and severity but does not replace prescription treatment for active flares.
The Exomega Control Cream succeeds by matching formulation to adherence. Clinical evidence for daily emollient use in atopic-prone skin depends on whether users apply the product every day. A well-formulated cream that feels pleasant enough for twice-daily use for a year produces better outcomes than an intensive product that gets skipped every third day. The Exomega Control Cream is a thoughtfully calibrated atopic body moisturizer on the pharmacy shelf. It does enough to matter and is light enough to use; that combination is its value.
Ingredient analysis.
Full INCI list
Aqua, Glycerin, Caprylic/Capric Triglyceride, Propanediol, Pentylene Glycol, Butyrospermum Parkii Butter, Avena Rhealba Extract, Helianthus Annuus Seed Oil Unsaponifiables, Niacinamide, Cetearyl Alcohol, Glyceryl Stearate, Dimethicone, Filipendula Ulmaria Extract, Tocopherol, Xanthan Gum, Disodium EDTA, Sodium Hydroxide, Phenoxyethanol
Skin match.
The science.
The Science
The evidence base for this cream is essentially the same as for the Exomega Control Balm, because the active ingredient set is identical. The defining study supporting the daily-emollient approach to atopic-prone skin is the 2014 trial published in the Journal of Allergy and Clinical Immunology, which followed high-risk infants for six months and documented a significantly reduced incidence of atopic dermatitis among those who received daily emollient application from early infancy. A 2017 Pediatric Dermatology review reinforced the finding and discussed the mechanisms: reduced transepidermal water loss, more intact barrier function, reduced frequency and severity of inflammatory flares.
The sunflower oil unsaponifiables in this formula are specifically chosen for their role in supporting the essential fatty acid composition of the stratum corneum lipid matrix. A 2018 paper in the International Journal of Molecular Sciences discussed the role of topical linoleic acid in activating PPAR-alpha and enhancing filaggrin expression in compromised skin — a mechanism that directly addresses one of the root metabolic problems in atopic dermatitis rather than just providing surface occlusion. Niacinamide's role in driving endogenous ceramide synthesis was documented in a 2005 British Journal of Dermatology paper showing improved barrier function and reduced transepidermal water loss after several weeks of topical use. And Rhealba oat extract has the Pierre Fabre-published research on anti-inflammatory marker modulation in reactive and compromised skin.
The texture choice — cream rather than balm — does not meaningfully affect the efficacy of these actives at the concentrations used. What the texture affects is adherence, which is the real determinant of clinical outcome in daily atopic skin management. A cream that's applied consistently twice a day will outperform a balm that's applied inconsistently, even if the balm is nominally more occlusive. This is the pragmatic logic behind offering the same active set in two different textures: matching the product to the real-world conditions of use is as important as matching it to the skin biology.
Dermatologist Perspective
Dermatologists commonly recommend the Exomega Control Cream as a daily maintenance emollient for atopic-prone children and adults, particularly in warmer climates or for users who find the balm variant too rich for daily use. Board-certified dermatologists note that the active ingredient set is the same across the cream and balm, and that the choice between them is primarily a matter of texture preference and severity. The cream is typically recommended for twice-daily application to damp skin after bathing, as part of a routine that also includes a gentle syndet cleanser and any prescribed topical treatments. It is widely considered an appropriate supportive product for maintaining atopic-prone skin between flares.
Where it fits in your routine.
Apply liberally to damp skin after bathing or showering twice daily for atopic-prone skin maintenance. Use head to toe or on specific affected areas. Apply more often during flares. Pair with a gentle syndet cleanser or emollient bath oil to prevent skin stripping. The cream is safe to use with prescription eczema treatments — apply prescription topicals first, then the cream once they absorb.
At roughly 26 dollars for 200ml, the Exomega Control Cream costs slightly less than the balm variant and similar to other pharmacy-brand atopic body creams. A larger 400ml size exists in some markets and gives better per-ml value for heavy daily users — families with multiple eczema-prone children should buy it. The 200ml size lasts 4 to 6 weeks with daily full-body use. The Exomega Control Cream costs more than simpler drugstore eczema creams because it uses a specific Rhealba oat and sunflower oil unsaponifiables formulation, though budget-conscious users get basic emollient benefit from cheaper alternatives.
Adults and children with mild to moderate atopic-prone skin, people who find the Exomega Control balm too heavy for daily use, users in temperate or warm climates, and anyone building a preventative daily eczema routine.
Severely dry atopic skin needs the full occlusive weight of a proper balm. This cream works for users satisfied with drugstore alternatives and those seeking non-prescription treatment for active eczema flares. It is a daily maintenance product, not an acute-phase treatment.
Product details.
Fragrance-free.
Airless pump bottle; 200ml standard with larger 400ml option in some markets.
This feels lighter and absorbs faster than the balm counterpart, but still provides the cushioned feeling atopic-prone skin needs. It has no tingling, no fragrance, and no surprises. It works for daily year-round use and suits summer better than the balm.
200ml lasts 4-6 weeks with daily full-body use.
12 months
All Year
The backstory.
A-Derma developed the Exomega Control line to serve atopic-prone skin across ages and seasons. The cream and balm share the same core active ingredients in different emollient bases, letting users and pediatric dermatologists choose the appropriate texture based on severity and climate.
About A-Derma
Legacy Brand (20+ years)A-Derma's Exomega Control line is Pierre Fabre's range for atopic-prone skin. It has the AFPADA recommendation and European pediatric dermatologists widely recommend it.
Common myths.
A lighter cream can't manage eczema-prone skin.
For mild to moderate atopic-prone skin, a well-formulated cream often works and users apply it more consistently than a heavier balm. Adherence reduces long-term flares more than absolute occlusion.
All body moisturizers are the same for eczema.
The specific mix of lipid-replenishing actives, anti-inflammatory agents, and barrier-supporting ingredients matters. A simple glycerin-based body lotion does not equal a formulation like this one.
FAQ.
Should I choose the Exomega Control Cream or the Balm?
Use the cream for milder atopic-prone skin, daily use, warmer climates, or faster absorption. Use the balm for severe dryness, cold weather, or a more occlusive protective layer. Both share the same core active ingredient set.
Can I use this cream on my child?
Yes. European pediatric dermatologists often recommend The Exomega Control line for atopic-prone children from infancy. Ask your pediatrician to confirm use for infants.
How often should I apply it?
Apply once or twice daily to maintain atopic-prone skin. Use it more often during flares or dry weather. Apply to damp skin after bathing.
Can it replace prescription eczema treatment?
No. This is a daily preventative and supportive emollient. Active flares typically require prescription topicals. Use this cream with, not instead of, prescribed treatments.
Will it pill under clothing?
No. The cream absorbs into a non-greasy finish in about a minute. It leaves no residue on clothing once absorbed. Wait one minute to sink in before dressing.
Is it suitable for keratosis pilaris?
Yes. Consistent use of the niacinamide and emollient base helps the rough-bumpy texture of keratosis pilaris. For more active KP treatment, use a urea or lactic acid product a few times a week.
How long does one pump bottle last?
A 200ml bottle lasts 4 to 6 weeks if applied to the full body daily. Some markets offer a 400ml size, which has better per-ml value for heavy users.
What the community says.
"lighter than the balm but still effective"
"good for year-round use"
"fragrance-free with consistent results"
"safe for children and adults"
"less intensive than the balm for severe dryness"
"standard drugstore-competitive pricing for pharmacy brand"
"limited US retail availability"